1
TITLE: Irinotecan (Iri) plus docetaxel (Doc) every 3 weeks in chemotherapy naive patients (pts) with inoperable non-small cell lung cancer (NSCLC): results of a phase II study
AUTHORS: Reiner Bonnet; Rafael Roseli; Janos Strausz; Evaristo Sanches; Mariano Provencio; Jean Marc Vernejoux; Herve Lena; Michael L Gershanovich; Blandine Boussard; Joachim von Pawel;
PUBLISHED: 2004, SOURCE: ANNALS OF ONCOLOGY, VOLUME: 15
INDEXED IN: WOS